These 3 Stocks Have Nothing in Common … Except Their Chart Trends
An apparel play, adhesives company and a biotech are all moving in the same direction: down.
You've reached your free article limit
You've read 0 of 1 free Pro articles.
Here we have a diverse group of bearish charts that could make for good shorts. One is a clothing play, another an adhesives maker and another a gene therapy biotech that had been on an uptrend. Let’s examine each chart as they make their way south.
Holes Appear in Chart of Gildan Activewear
The downtrend channel on Gildan (GIL) is well established, lower-highs and lower-lows as the stock has been trounced in 2026. Clearly the consumer has other ideas in retail than Gildan, and investors abhor the brand as well. Money flow, as seen at the bottom of the chart, has been super weak for months, barely hitting green on two occasions but just not enough to break the downtrend.
The moving average convergence divergence is on a sell signal, relative strength oversold but that is no reason to buy. We may get a test back into the channel but that would be a sell/short signal. Let’s put a short on here at the $40 level, aggressively target the $30 spot (old support area). Put in a stop at $46 just in case.
HB Fuller Just Won’t Stick
You can really see the bearish pattern setup in adhesives and sealant company HB Fuller (FUL) with some wide, volatile moves over the past several months. Eventually the heavy volatility leads to some sort of break, and this week saw that support melt at the March lows. The stock has really been under a ton of pressure since a lower-high peak was printed in August.
Money flow has been poor, and the MACD on a double-sell signal. Relative Strength has been oversold, but that is no reason to buy. Volume trends have turned bearish. Let’s target the $42 level and then further down to $38, put in a stop at $52 just in case. This break if confirmed is quite bearish.
No ‘QURE’ for Investors
An ugly break of a symmetrical triangle to the downside plagues gene therapy company UniQure (QURE), as the stock looks destined for even lower prices. One more down day would confirm the trend, with heavy downside action lately. Volume trends are not wildly bearish, though, which means maybe a reversal could be a surprise. But I don’t think that will be an issue this time, the big gap is open and begs to be filled.
That would be the $27.50 area, but if probed we could see even more downside to the $22 area. This stock is volatile, and could snap back at any point. Let’s target the $22 area for a nice profit gain, a stop at $45 just in case.
At the time of publication, Lang had no position in any security mentioned.
